The trajectory of companies tied to iconic drugs like Viagra presents a complex investment scenario . While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the expiry in key regions has introduced substantial uncertainty . Investors are now assessing the effect of rival medications , reduc